251 related articles for article (PubMed ID: 3484992)
21. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
[TBL] [Abstract][Full Text] [Related]
22. Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA.
Reader TA; Gauthier P
J Neural Transm; 1984; 59(3):207-27. PubMed ID: 6234377
[TBL] [Abstract][Full Text] [Related]
23. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
Willoughby JO; Menadue M; Jervois P
Brain Res; 1982 Oct; 249(2):291-9. PubMed ID: 6291713
[TBL] [Abstract][Full Text] [Related]
24. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
[TBL] [Abstract][Full Text] [Related]
25. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
26. Antimyoclonic properties of S2 serotonin receptor antagonists in the rat.
Pranzatelli MR; Snodgrass SR
Neuropharmacology; 1986 Jan; 25(1):5-12. PubMed ID: 2936977
[TBL] [Abstract][Full Text] [Related]
27. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
[TBL] [Abstract][Full Text] [Related]
28. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
Brown LM; Smith DL; Williams GM; Smith DJ
Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
[TBL] [Abstract][Full Text] [Related]
29. Selective destruction of the serotonergic fibers of the fornix-fimbria and cingulum bundle increases 5-HT1 but not 5-HT2 receptors in rat midbrain.
Quik M; Azmitia E
Eur J Pharmacol; 1983 Jun; 90(4):377-84. PubMed ID: 6884427
[TBL] [Abstract][Full Text] [Related]
30. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
McElroy JF; Miller JM; Meyer JS
J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
[TBL] [Abstract][Full Text] [Related]
31. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
Xie T; Tong L; McLane MW; Hatzidimitriou G; Yuan J; McCann U; Ricaurte G
Neuropsychopharmacology; 2006 Dec; 31(12):2639-51. PubMed ID: 16452989
[TBL] [Abstract][Full Text] [Related]
32. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
Stewart RM; Campbell A; Sperk G; Baldessarini RJ
Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
[No Abstract] [Full Text] [Related]
33. [Anxiety-like behavior in rats neonatally and adultly treated with 5,7-dihydroxytryptamine].
Yamada I; Iwasaki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):145-51. PubMed ID: 12451684
[TBL] [Abstract][Full Text] [Related]
34. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
[TBL] [Abstract][Full Text] [Related]
35. Neurochemical effects of serotonin neurotoxins: an introduction.
Fuller RW
Ann N Y Acad Sci; 1978 Jun; 305():178-81. PubMed ID: 280249
[No Abstract] [Full Text] [Related]
36. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
Dewar KM; Grondin L; Carli M; Lima L; Reader TA
J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
[TBL] [Abstract][Full Text] [Related]
37. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
Currie PJ; Coscina DV; Fletcher PJ
Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
[TBL] [Abstract][Full Text] [Related]
38. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
Shabanov PD; Bul'on VV; Lénárd L
Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
[TBL] [Abstract][Full Text] [Related]
39. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of [3H]5-hydroxytryptamine binding sites in chick embryo brain by monoamine oxidase inhibitors or fenfluramine and potentiation by d,l-5-hydroxytryptophan.
Soblosky JS; DuMontier G; Jeng I
J Neurochem; 1985 Dec; 45(6):1923-31. PubMed ID: 3932597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
